Literature DB >> 15698883

The bion device: a minimally invasive implantable ministimulator for pudendal nerve neuromodulation in patients with detrusor overactivity incontinence.

J L H R Bosch1.   

Abstract

The results of the bion pilot studies indicate that a considerable reduction in the degree of detrusor overactivity incontinence can be obtained in severely refractory cases, including women who had failed sacral nerve neuromodulation. The described technique is well tolerated by the patients. It is minimally invasive and relatively simple. Clinical trials of the bion-r device involving larger numbers of patients are underway in the United States and Europe. A subchronic instead of the currently used acute screening test might increase the percentage of patients assessed as suitable candidates for implantation. There-fore, methods of performing a subchronic test of the pudendal nerve also are being investigated.

Entities:  

Mesh:

Year:  2005        PMID: 15698883     DOI: 10.1016/j.ucl.2004.09.003

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  7 in total

Review 1.  Alternative approaches to sacral nerve stimulation.

Authors:  Kenneth M Peters
Journal:  Int Urogynecol J       Date:  2010-12       Impact factor: 2.894

Review 2.  [Overactive bladder syndrome. Are there indications for surgical therapy?].

Authors:  J N Nyarangi-Dix; A Haferkamp; A Reitz; M Hohenfellner
Journal:  Urologe A       Date:  2006-10       Impact factor: 0.639

3.  Long-term efficacy of electrical pudendal nerve stimulation for urgency-frequency syndrome in women.

Authors:  Siyou Wang; Shujing Zhang; Lin Zhao
Journal:  Int Urogynecol J       Date:  2013-10-03       Impact factor: 2.894

4.  Bursting stimulation of proximal urethral afferents improves bladder pressures and voiding.

Authors:  Tim M Bruns; Narendra Bhadra; Kenneth J Gustafson
Journal:  J Neural Eng       Date:  2009-11-09       Impact factor: 5.379

Review 5.  Neuromodulation techniques: a comparison of available and new therapies.

Authors:  Sandip P Vasavada; Howard B Goldman; Raymond R Rackley
Journal:  Curr Urol Rep       Date:  2007-11       Impact factor: 3.092

6.  Refractory overactive bladder: Beyond oral anticholinergic therapy.

Authors:  Ronald W Glinski; Steven Siegel
Journal:  Indian J Urol       Date:  2007-04

Review 7.  Evaluation and Management of Neurogenic Bladder: What Is New in China?

Authors:  Limin Liao
Journal:  Int J Mol Sci       Date:  2015-08-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.